MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
about
Circulating microRNAs as biomarkers for disease staging in multiple sclerosisTissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancerMicro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?miRNA polymorphisms and risk of gastric cancer in Asian populationQuantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.MicroRNAs and the regulation of vector tropismFerritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.mRNA and microRNA expression profiles of the NCI-60 integrated with drug activitiesAlterations of microRNAs are associated with impaired growth of MCF-7 breast cancer cells induced by inhibition of casein kinase 2.Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtypemiRNA expression profiling of lung adenocarcinomas: correlation with mutational status.The clinical potential of microRNAsMicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis.Relationship between circulating and tissue microRNAs in a murine model of breast cancerIdentification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.miRNA Biomarkers in Breast Cancer Detection and ManagementIn vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging.The expression of LEP, LEPR, IGF1 and IL10 in obesity and the relationship with microRNAs.Role of microRNAs in the regulation of breast cancer stem cells.MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor developmentTamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cellsSystemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast.mRNA and microRNA expression profiles of radioresistant NCI-H520 non-small cell lung cancer cells.Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer.Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment.MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.miRNAs and estrogen action.Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance.The role of microRNAs in breast cancer migration, invasion and metastasisA systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerA MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
P2860
Q28287246-73BB4F61-12DC-4D1D-A99C-CC030851F2CBQ28478758-7F63F6D2-352A-4876-BFB6-5DAD2597E6B4Q33585105-648BDE73-BABA-4902-B9FD-FE4E84BBB02BQ33626800-89887A21-FBD3-4215-AD55-AB1EC981307EQ33697764-378773D6-D6C5-4503-BDB8-7AEECA2DB694Q33713311-7F94C715-09DA-427F-9171-30E964C87FB5Q33850657-12A9A80B-321A-4C3C-811E-2D31CA5A2F64Q33889761-FCE39B86-513C-4839-8F6D-22025205B2BBQ34029090-2717A266-B899-4FCE-8146-9A3F3B8E5385Q34129423-DE594EF7-7E8D-4006-A221-0FE0FA59D36FQ34136203-693B61C3-F6F3-4A44-8E64-5CAF11C52135Q34220723-F9C89BCD-74C1-4E88-A3D8-559D2A58B884Q34412920-C32DBBE7-C754-43F3-ADA6-2BB79AC46DB6Q34505424-8B67A21B-EEAA-4148-9616-27740D51EF15Q34599349-852F6739-0A40-4D02-957B-2F4F9600DE69Q34771896-D7156446-8009-47A9-825C-EB74669A2A86Q34949654-36A30118-1720-43A7-A595-699D88C09CE8Q35137465-BAF02A0F-022C-4593-9717-57A1589F169EQ35190678-25BEA869-C454-41C7-B5DE-6E2190059C08Q35207545-29413FE8-FF6B-4361-A56E-0A0F7CC1AB5FQ35218111-53309CBA-11D4-4D7A-ABD0-DE1AEDF98A88Q35526554-7FC30124-CFF4-4C9B-B5B8-04B85FB6D9CBQ35550117-5B518D86-947E-4A19-91E8-73C7E2BA8993Q35584190-9740F0D4-38D0-4980-941D-8581E0B8FDDCQ35661627-4B3B8379-2DA0-4885-A415-F316DB952438Q35713817-DED4E1C7-11C6-41F9-ACDF-C1F759B1706DQ35728606-5118F1B6-A907-4D45-939C-91F56CA06697Q35786673-C3854F37-B607-45ED-AC53-AA279C5C5A45Q35857777-FFDD562B-A738-40C7-BC74-2536121CFC0EQ35887447-5072FEB6-BCA2-449F-B39C-4B711885EB7FQ35893422-530C7513-C8CE-4FAB-A0E0-2BED757ACC3BQ35912303-9036AE38-7E95-4A2A-8659-9C07657D554DQ35946984-7A2BBABC-8FFC-40DC-81D9-A9E8A06799BCQ36046299-FF9E3559-EF28-4039-87C4-628397449EA9Q36293886-EE002956-3C3B-4C09-B14C-7153162B8BC5Q36396579-E25EB010-0BA3-47E8-95B4-BF9C96766BE4Q36437698-405CD84B-3D1D-4BE6-AA51-2D70882F8915Q36544789-7D9E290E-2B94-4591-9D1E-563FBEF5B65EQ36546638-22C08302-1C1E-4B1D-BF0C-84616521D966Q36636769-2B3197B1-47A1-47E4-8250-83DDE81A67FF
P2860
MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs as prognostic indica ...... t on breast cancer management.
@en
MicroRNAs as prognostic indica ...... t on breast cancer management.
@nl
type
label
MicroRNAs as prognostic indica ...... t on breast cancer management.
@en
MicroRNAs as prognostic indica ...... t on breast cancer management.
@nl
prefLabel
MicroRNAs as prognostic indica ...... t on breast cancer management.
@en
MicroRNAs as prognostic indica ...... t on breast cancer management.
@nl
P2093
P1476
MicroRNAs as prognostic indica ...... t on breast cancer management.
@en
P2093
Aoife J Lowery
Michael J Kerin
Nicola Miller
Roisin E McNeill
P304
P356
10.1158/1078-0432.CCR-07-0992
P407
P577
2008-01-01T00:00:00Z